Integra LifeSciences Holdings Corporation · NASDAQ:IART

Integra LifeSciences Holdings Corporation financial statements

Integra LifeSciences Holdings Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.64B1.61B1.54B1.56B1.54B1.37B1.52B1.47B1.19B992.1M
Cost of revenue803.6M728.5M656.8M587.4M597.8M520.8M564.7M571.5M435.5M349.1M
Gross profit831.6M882.1M884.7M970.3M944.6M851.0M952.9M900.9M752.7M643.0M
Research and development99.0M115.4M104.2M101.2M93.1M77.4M79.6M78.0M63.5M58.2M
Selling, general and administrative699.7M717.0M656.6M616.3M637.4M594.5M687.6M690.7M624.1M455.6M
Operating income-493.4M28.4M111.5M238.9M197.2M151.4M93.8M111.0M44.8M115.3M
Depreciation and amortization44.8M42.4M40.9M40.1M39.4M42.1M109.5M110.7M88.9M72.7M
EBITDA-448.6M70.8M152.4M279.0M236.6M193.5M203.2M221.7M133.7M188.0M
Interest expense86.3M70.6M51.4M49.6M50.4M71.6M54.0M64.7M35.0M25.8M
Income before tax-563.5M-18.2M81.1M213.9M214.7M93.5M60.1M57.4M11.4M90.4M
Income tax-47.0M-11.3M13.3M33.3M45.6M-40.4M9.90M-3.40M-53.4M15.8M
Net income-516.5M-6.94M67.7M180.6M169.1M133.9M50.2M60.8M64.7M74.6M
Earnings per share, basic-6.74-0.090.852.182.001.580.590.730.841.00
Earnings per share, diluted-6.74-0.090.842.161.981.570.580.720.820.94

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents235.0M246.4M276.4M456.7M513.4M470.2M198.9M138.8M174.9M102.1M
Short-term investments28.7M27.2M32.7M00
Receivables278.8M272.4M259.3M263.5M231.8M225.5M275.3M265.7M251.8M148.2M
Inventory492.7M429.1M389.6M324.6M317.4M310.1M316.1M280.3M296.3M217.3M
Current assets1.16B1.08B1.06B1.16B1.15B1.24B858.2M775.1M822.1M495.2M
Property, plant and equipment444.3M405.7M340.2M311.3M311.7M287.5M337.4M300.1M269.3M222.4M
Goodwill615.2M1.10B1.06B1.04B1.01B932.4M954.3M926.5M937.9M510.6M
Total assets3.60B4.04B3.78B3.89B3.78B3.62B3.30B3.11B3.21B1.81B
Current liabilities456.0M922.1M307.0M320.9M340.0M401.0M331.3M262.6M348.9M123.6M
Total debt726.6M760.5M775.0M775.0M843.8M877.5M877.5M900.0M
Total liabilities2.56B2.49B2.19B2.09B2.10B2.10B1.89B1.73B2.25B968.3M
Shareholders' equity1.04B1.55B1.59B1.80B1.68B1.51B1.42B1.38B962.3M839.7M
Shares outstanding77.8M77.8M77.9M77.9M77.2M78.2M81.6M83.2M84.4M84.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations50.4M129.4M140.0M264.5M312.4M203.8M231.4M199.7M114.5M116.4M
Capital spending-81.4M-104.4M-66.9M-42.3M-48.0M-38.9M-69.5M-77.7M-43.5M-47.3M
Free cash flow-31.1M25.0M73.1M222.1M264.4M164.9M161.9M121.9M71.0M69.1M
Cash from investing-108.1M-390.8M-94.2M-58.6M-161.4M-68.1M-162.7M-49.7M-1.22B-42.6M
Cash from financing28.3M237.9M-229.9M-252.0M-98.2M121.6M-8.77M-180.9M1.17B-15.1M
Share buybacks-221.0K-52.5M-275.0M-125.0M0-100.0M00
Change in cash-11.3M-30.0M-180.3M-56.8M43.3M271.3M60.1M-36.1M72.9M53.9M